Profile
| Metric | Value |
|---|---|
| Full Name | Kiniksa Pharmaceuticals International, plc |
| Ticker | NASDAQ: KNSA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United Kingdom |
| IPO | |
| Indexes | Not included |
| Website | kiniksa.com |
| Employees | 315 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $43.52 | |
| Price, 1D Change | -3.20% | |
| $3B | ||
| - | ||
| 97.08 | ||
| 0.50 | ||
| $423M | ||
| Revenue, 1Y Change | +56.60% | |
| -$0.60 | ||
| EPS, 1Y Change | -408.84% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.60 | ||
| EPS Estimate | $1.05 | |
| EPS Est. Change | +274.05% | |
| $423.24M | ||
| Revenue Estimate | $676.37M | |
| Revenue Est. Change | +59.81% | |
| Current Price | $43.52 | |
| Price Target | - | $55.00 |
| Price Tgt. Change | - | +26.38% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.30 | $0.20 | +165.27% | |
| -$0.21 | -$0.60 | -183.50% | |
| $1.05 | N/A | +274.05% | |
| $1.53 | N/A | +352.19% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $256.74M | $270.26M | +5.27% | |
| $424.18M | $423.24M | -0.22% | |
| $676.37M | N/A | +59.81% | |
| $909.47M | N/A | +114.88% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $43.52 | |
| $34.64 | ||
| SMA 200 vs Price | -20.41% | |
| $41.87 | ||
| SMA 50 vs Price | -3.79% | |
| 0.50 | ||
| $1.69 | ||
| 54.66 | ||
| 34.61% | ||
| 43.47% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $423.24M | ||
| -$0.60 | ||
| $233.57M | ||
| 55.19% | ||
| -$45.62M | ||
| -10.78% | ||
| -$43.19M | ||
| -10.21% | ||
| -$43.92M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| 3.30 | ||
| 3.04 | ||
| - | ||
| 7 | ||
| 13.62 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 97.08 | ||
| 5.52 | ||
| 6.16 | ||
| 74.58 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $438.44M | ||
| $183.58M | ||
| $580.55M | ||
| $331.80M | ||
| $142.12M | ||
| $100.62M | ||
| $9.86M | ||
| $1.99M | ||
| $2.04M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $468.86M | ||
| $407.95M | ||
| $189.67M | ||
| $168.01M | ||
| $1.70M | ||
| $0.00 | ||
| $7.04M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $25.69M | ||
| $37.67M | ||
| $12.27M | ||
| $277.00K | ||
| $25.41M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wedbush | → | |
| Goldman Sachs | → | |
| Citigroup | → | |
| Wedbush | → | |
| TD Cowen | ||
| Wells Fargo | → | |
| Jefferies | → | |
| Wells Fargo | → | |
| Jefferies | → | |
| Wedbush | → |
Analyst sentiment
Institutional ownership
Screeners with KNSA
FAQ
What is the ticker symbol for Kiniksa Pharmaceuticals International, plc?
The ticker symbol for Kiniksa Pharmaceuticals International, plc is NASDAQ:KNSA
Does Kiniksa Pharmaceuticals International, plc pay dividends?
No, Kiniksa Pharmaceuticals International, plc does not pay dividends
What sector is Kiniksa Pharmaceuticals International, plc in?
Kiniksa Pharmaceuticals International, plc is in the Healthcare sector
What industry is Kiniksa Pharmaceuticals International, plc in?
Kiniksa Pharmaceuticals International, plc is in the Specialty & Generic Drug Manufacturers industry
What country is Kiniksa Pharmaceuticals International, plc based in?
Kiniksa Pharmaceuticals International, plc is headquartered in United Kingdom
When did Kiniksa Pharmaceuticals International, plc go public?
Kiniksa Pharmaceuticals International, plc initial public offering (IPO) was on May 25, 2018
Is Kiniksa Pharmaceuticals International, plc in the S&P 500?
No, Kiniksa Pharmaceuticals International, plc is not included in the S&P 500 index
Is Kiniksa Pharmaceuticals International, plc in the NASDAQ 100?
No, Kiniksa Pharmaceuticals International, plc is not included in the NASDAQ 100 index
Is Kiniksa Pharmaceuticals International, plc in the Dow Jones?
No, Kiniksa Pharmaceuticals International, plc is not included in the Dow Jones index
When was Kiniksa Pharmaceuticals International, plc last earnings report?
Kiniksa Pharmaceuticals International, plc's most recent earnings report was on October 28, 2025
When does Kiniksa Pharmaceuticals International, plc report earnings?
The next expected earnings date for Kiniksa Pharmaceuticals International, plc is March 3, 2026
Data Sources & References
- KNSA Official Website www.kiniksa.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1730430/000110465925103180/0001104659-25-103180-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1730430/000155837025001505/0001558370-25-001505-index.htm
- KNSA Profile on Yahoo Finance finance.yahoo.com/quote/KNSA
- KNSA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/knsa